| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $0.03842 (Miss by $-0.08158) |
| EPS GAAP Actual | $0.03842 (Miss by $-0.08158) |
| Revenue Actual | $0.67683B |
| Revenue Surprise | Beat by $676.83M |
| Announce Date | 03/27/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.23496 |
| EPS GAAP Estimate | $0.23496 |
| Revenue Estimate | $0.68759446B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 1.8 | 2.7 | 1.77292 | 1.83735 | 1 |
| Dec 2027 | 1.27612 | 3.81 | 1.2428 | 1.30227 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.04 | -0.08357 | 0.67683B | 100% | -5.78M |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 0.70011B | 100% | 700.11M |
| FQ1 2025 (Mar 2025) | 0.18 | 0.18 | 0.668244B | 100% | 668.24M |
| FQ4 2024 (Dec 2024) | -1.17 | -1.17 | 0.646956B | 100% | 646.96M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.329047B | 100% | 329.05M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.329047B | 100% | 329.05M |
| FQ1 2021 (Mar 2021) | -0.21 | -0.21 | 0.400262B | 17.79% | 400.26M |
| FQ2 2021 (Jun 2021) | 0 | 0 | 0.456916B | 27.99% | 456.92M |
FQ4 Announce Date
03/27/2026 (Pre-Market)
Consensus EPS Estimates
0.23496
Consensus Revenue Estimates
0.68759446B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.20732 | -- | 0.20162 | 0.21233 | 3 |
| FQ3 2027 (Sep 2027) | 0.17426 | -- | 0.16947 | 0.17847 | 4 |
| FQ2 2027 (Jun 2027) | 0.27998 | -- | 0.27228 | 0.28675 | 5 |
| FQ1 2027 (Mar 2027) | 0.23929 | -- | 0.23271 | 0.24507 | 2 |
| FQ4 2026 (Dec 2026) | 0.20715 | -- | 0.20145 | 0.21216 | 2 |
| FQ3 2026 (Sep 2026) | 0.16477 | 75.72 | 0.16024 | 0.16875 | 2 |
| FQ2 2026 (Jun 2026) | 0.25986 | -26.99 | 0.25271 | 0.26614 | 2 |
| FQ1 2026 (Mar 2026) | 0.23496 | 23.39 | 0.20305 | 0.26016 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.72B | -- | 0.7B | 0.73B | 2 |
| FQ3 2027 (Sep 2027) | 0.73B | -- | 0.72B | 0.75B | 2 |
| FQ2 2027 (Jun 2027) | 0.75B | -- | 0.74B | 0.77B | 2 |
| FQ1 2027 (Mar 2027) | 0.72B | -- | 0.7B | 0.73B | 2 |
| FQ4 2026 (Dec 2026) | 0.7B | -- | 0.69B | 0.72B | 2 |
| FQ3 2026 (Sep 2026) | 0.71B | 4.15 | 0.69B | 0.72B | 2 |
| FQ2 2026 (Jun 2026) | 0.72B | 2.99 | 0.71B | 0.74B | 2 |
| FQ1 2026 (Mar 2026) | 0.69B | 2.81 | 0.68B | 0.7B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
3
EPS # of in-lines
3
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12357 | 0.04 | -0.08357 | -208.93% |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 100% | |
| FQ1 2025 (Mar 2025) | 0.18 | 0.18 | 100% | |
| FQ4 2024 (Dec 2024) | -1.17 | -1.17 | 100% | |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% | |
| FQ1 2021 (Mar 2021) | -0.21 | -0.21 | 100% | |
| FQ2 2021 (Jun 2021) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.68B | $0.68B | $-5.78M | -0.85% |
| FQ2 2025 (Jun 2025) | $0B | $0.7B | $700.11M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.67B | $668.24M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.65B | $646.96M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.33B | $329.05M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.33B | $329.05M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $0.4B | $400.26M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $0.46B | $456.92M | 100% |